Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...

Humira was previously approved for psoriatic arthritis at a dose of one injection every other week. When the drug was approved for use in people coping with psoriasis, a dose was added which ...

Findings by Johnson & Johnson’s pharma unit show that psoriasis sufferers can use its Tremfya (guselkumab) when AbbVie's blockbuster Humira doesn ... safety data and no injection site reactions.

The injection is given in the thigh or abdomen ... If you are using this medication to treat psoriasis, hidradenitis suppurativa, Crohn's disease, ulcerative colitis, or uveitis, your doctor ...

The Department of Veterans Affairs (VA) saved $67 million in 2023 through its strong adoption of biosimilars to curb the high ...

Humira is a versatile drug used to treat multiple autoimmune diseases, such as rheumatoid arthritis, Crohn’s disease, psoriasis ... designed to decrease injection volume for higher doses ...

UnitedHealth to Remove AbbVie's Humira From Some US Drug Reimbursement ... differences in the risk for PsA among patients with psoriasis treated with interleukin (IL)-23 inhibitors and those ...

Humira has been a blockbuster worldwide for nearly two decades. The biologic has multiple indications, including rheumatoid arthritis, Crohn’s disease and psoriasis. The Foundation asserts that ...